Oxysterols and related sterols: chemical, biochemical and biological aspects, Steroids, vol.99, pp.117-118, 2015. ,
Oxysterols and related sterols: implications in pharmacology and pathophysiology, Biochem. Pharmacol, vol.86, pp.1-2, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00832422
Identification of natural RORgamma ligands that regulate the development of lymphoid cells, Cell Metab, vol.21, pp.286-297, 2015. ,
,
Oxysterols are agonist ligands of RORgammat and drive Th17 cell differentiation, Proc. Natl. Acad. Sci. U.S.A, vol.111, pp.12163-12168, 2014. ,
Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon, Science, vol.345, pp.679-684, 2014. ,
Cholestenoic acids regulate motor neuron survival via liver X receptors, J. Clin. Invest, vol.124, pp.4829-4842, 2014. ,
Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis, Nat. Chem. Biol, vol.9, pp.126-133, 2013. ,
Dendrogenin A: a mammalian metabolite of cholesterol with tumor suppressor and neurostimulating properties, Curr. Med. Chem, vol.22, pp.3533-3549, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02380776
,
, , 2013.
, Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties, Nat. Commun, vol.4, 1840.
Four decades of discovery in breast cancer research and treatment -an interview with V. Craig Jordan, Int. J. Dev. Biol, vol.55, pp.703-712, 2011. ,
Selective estrogen receptor modulation: concept and consequences in cancer, Cancer Cell, vol.5, pp.207-213, 2004. ,
Multiple targeting by the antitumor drug tamoxifen: a structure-activity study, Curr. Med. Chem. Anticancer Agents, vol.4, pp.491-508, 2004. ,
URL : https://hal.archives-ouvertes.fr/inserm-00090772
Cellular and molecular pharmacology of antiestrogen action and resistance, Pharmacol. Rev, vol.53, pp.25-71, 2001. ,
Molecular characterization of the microsomal tamoxifen binding site, J. Biol. Chem, vol.279, pp.34048-34061, 2004. ,
URL : https://hal.archives-ouvertes.fr/inserm-00090773
Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism, Oncotarget, vol.4, pp.911-922, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00968940
,
) 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells, Biochem. Pharmacol, vol.86, pp.175-189, 2013. ,
,
Cholesterol epoxide hydrolase and cancer, Curr. Opin. Pharmacol, vol.12, pp.696-703, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00743463
,
Cholesterol metabolism and resistance to tamoxifen, Curr. Opin. Pharmacol, vol.12, pp.683-689, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00743466
Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands, Chem. Phys. Lipids, vol.164, pp.432-437, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00743454
Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands, Proc. Natl. Acad. Sci. U.S.A, vol.107, pp.13520-13525, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00519159
,
Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation, Autophagy, vol.5, pp.1066-1067, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00519150
,
Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism, Cell Death Differ, vol.16, pp.1372-1384, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00519149
Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism, Mol. Cancer Ther, vol.7, pp.3707-3718, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00519145
Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways, Breast Cancer Res, vol.7, pp.1159-1167, 2005. ,
URL : https://hal.archives-ouvertes.fr/inserm-00089309
Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS), Bioorg. Med. Chem, vol.8, pp.2007-2016, 2000. ,
URL : https://hal.archives-ouvertes.fr/inserm-00090778
Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor, Biochem. Pharmacol, vol.58, pp.1927-1939, 1999. ,
URL : https://hal.archives-ouvertes.fr/inserm-00090780
Modifications of benzylphenoxy ethanamine antiestrogen molecules: influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity, Biochem. Pharmacol, vol.57, pp.657-661, 1999. ,
URL : https://hal.archives-ouvertes.fr/inserm-00090781
N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine in combination with cyclophosphamide: an active, low-toxicity regimen for metastatic hormonally unresponsive prostate cancer, J. Clin. Oncol, vol.13, pp.1398-1403, 1995. ,
The anti-proliferative properties of 4-benzylphenoxy ethanamine derivatives are mediated by the anti-estrogen binding site (ABS), whereas the anti-estrogenic effects of trifluopromazine are not, Biochem. Pharmacol, vol.40, pp.425-429, 1990. ,
URL : https://hal.archives-ouvertes.fr/inserm-00090799
,
Further evidence for a biological role of anti-estrogen-binding sites in mediating the growth inhibitory action of diphenylmethane derivatives, Chem. Biol. Interact, vol.66, pp.101-109, 1988. ,
URL : https://hal.archives-ouvertes.fr/inserm-00090800
,
Correlation of the antiproliferative action of diphenylmethane-derivative antiestrogen binding site ligands with antagonism of histamine binding but not of protein kinase C-mediated phosphorylation, Cancer Res, vol.48, pp.3954-3958, 1988. ,
A diphenylmethane derivative selective for the anti-estrogen binding site may help define its biological role, Biochem. Biophys. Res. Commun, vol.124, pp.244-249, 1984. ,
Cancer. Cholesterol and cancer, in the balance, Science, vol.343, pp.1445-1446, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-00968924
Cholesterol-5,6-epoxides: chemistry, biochemistry, metabolic fate and cancer, Biochimie, vol.95, pp.622-631, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00743461
Surprising unreactivity of cholesterol-5,6-epoxides towards nucleophiles, J. Lipid. Res, vol.53, pp.718-725, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00743457
Synthesis of new alkylaminooxysterols with potent cell differentiating activities: identification of leads for the treatment of cancer and neurodegenerative diseases, J. Med. Chem, vol.52, pp.7765-7777, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00519151
,
Malformation syndromes caused by disorders of cholesterol synthesis, J. Lipid. Res, vol.52, pp.6-34, 2011. ,
,
Dendrogenin A and B two new steroidal alkaloids increasing neural responsiveness in the deafened guinea pig, Front. Aging Neurosci, vol.7, p.145, 2015. ,
The novel steroidal alkaloids dendrogenin A and B promote proliferation of adult neural stem cells, Biochem. Biophys. Res. Commun, vol.446, pp.681-686, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-00968932
Chemistry and anticarcinogenic mechanisms of glycoalkaloids produced by eggplants, potatoes, and tomatoes, J. Agric. Food Chem, vol.63, pp.3323-3337, 2015. ,
Squalamine as an example of a new potent antimicrobial agents class: a critical review, Curr. Med. Chem, vol.17, pp.3909-3917, 2010. ,
Natural products: a continuing source of novel drug leads, Biochim. Biophys. Acta, vol.1830, pp.3670-3695, 2013. ,
,
Biotransformation of cholesterol to cholestane-3beta,5alpha,6beta-triol via cholesterol alpha-epoxide (5alpha,6alpha-epoxycholestan-3beta-ol) in bovine adrenal cortex, J. Biol. Chem, vol.254, pp.3854-3860, 1979. ,